Atai stock forecast.

The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are ...3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, …ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...

1.04%. $183.15M. AMAM | Complete Ambrx Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Cybin Inc. (OTC: CLXPF) stock has returned more than 3,485% to investors in the past twelve months. The firm operates as a life sciences company concentrating on the development of psychedelic drugs.

Atai Life Sciences has a strong financial position with $227.5 million in cash and funding to support its operations into the 1st half of 2026. The global schizophrenia drug market is expected to ...

This stake is worth roughly $98M as of Tuesday, March 28, based on COMPASS Pathways’ closing price of $10.23/share on that day. You can find atai’s filed 10-K from last Friday here. With ...43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.WebAs of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.May 25, 2023 · These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...

Ad. LendingTree. As we look ahead to 2024, some of the most promising AI-powered stock-picking platforms use natural language processing to generate actionable predictions. For example, EquBot ...

See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Nov 24, 2023 · NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October. Atai Life Sciences Nv (ATAI) Share Price Forecast. Currently 15 wall-street analysts regularly analyze the financials of Atai Life Sciences Nv on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Atai Life Sciences Nv (ATAI) have a share price target of $12.32.View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET...Historical daily share price chart and data for Atai Life Sciences since 2008 adjusted for splits and dividends. The latest closing stock price for Atai ...111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ...

ATA Inc-China Net Income Forecast for 2023 - 2025 - 2030. In the last year, ATA Inc-China has seen a decline in its Net Income, from $-169.84M to $-167.81M – a 1.20% decrease. In the next year, analysts predict that Net Income will reach $-169.84M – an increase of 1.21%. For the next nine years, the forecast is for Net Income to grow by …

Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.Find the latest Global Partners LP (GLP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ... View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.ATAI / ATAI Life Sciences N.V. - Forecast and Price Target https://fintel.io/sfo/us/atai. See More. Bullish. Reply. Keep. Last Read. Share. Copy Message ...Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price. View analysts price targets for CMPS or view top-rated stocks among Wall Street analysts.

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...

Atai Life Sciences has a strong financial position with $227.5 million in cash and funding to support its operations into the 1st half of 2026. The global schizophrenia drug market is expected to ...

3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.ATAI Life Sciences N.V. Watch Set a price target alert Premarket Last Updated: Nov 15, 2023 8:18 a.m. EST Delayed quote $ 1.2900 0.04 2.79% Before Hours Volume: 2.23K …WebATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00. 20. 11. 2023. ... The company's 5Y monthly beta was ticking 0.83. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.65 ...NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.0. These 7 analysts have an average price target of $13.29 versus the current price of ATAI Life Sciences at $1.3447, implying upside. Below is a summary of how these 7 analysts rated ATAI Life ...24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...Atai's stock is hurting, but its pipeline is still packed with promising programs. CMPS: 6.10 (+2.01%) ATAI: 1.1200 (+7.69%) Why Shares of Atai Life Sciences Rose Friday Motley Fool - Fri Mar 31, 1:49PM CDT . ... Cash Markets Overview Corn Indexes Soybean Indexes Yield Forecast Indexes. European Futures.Oct 24, 2023 · Ad. LendingTree. As we look ahead to 2024, some of the most promising AI-powered stock-picking platforms use natural language processing to generate actionable predictions. For example, EquBot ... Oct 2, 2023 · 3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, 2023.

ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.The forecasts range from a low of 5.15 to a high of $23.10. The average price target represents an increase of 605.71% from its latest reported closing price of 1.90. See our leaderboard of ...4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the company's stock price to reach $12.80 in the next twelve months. This suggests a possible upside of 1,063.6% from the stock's current price.ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ...Instagram:https://instagram. how to communicate better booksdouble leveraged etflowest forex spreads brokerwally weitz Dec 1, 2023 · Based on short-term price targets offered by four analysts, the average price target for atai Life Sciences N.V. comes to $13.00. The forecasts range from a low of $6.00 to a high of $20.00. The ... Oct 24, 2023 · Ad. LendingTree. As we look ahead to 2024, some of the most promising AI-powered stock-picking platforms use natural language processing to generate actionable predictions. For example, EquBot ... robert half international stockbest books for options trading How have NBSE shares performed in 2023? NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. best conventional loan lenders See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.